(The following press release from Merck KGaA was received by e-mail. It 
was not confirmed by the sender.) 
Ihr Ansprechpartner
Dr. Gangolf Schrimpf
+49(0)6151 72 9591 
Merck Millipore stellt Führungsposition in der Life-Science-Tools-Branche
im Rahmen einer Investorenkonferenz vor 
• Sparte ist einem der attraktivsten Segmente der Gesundheitsbranche gut
• Starke Markttrends und stetige Innovation als treibende Kräfte für
  profitables Wachstum
• Sparte will ab 2017 Netto-Kosteneinsparungen von 40 Mio € erzielen 
Darmstadt / Molsheim, Frankreich, 5. Dezember 2012 – Merck hat heute im
Rahmen einer Veranstaltung für Analysten und Investoren im französischen
Molsheim detaillierte Informationen zu seiner Life-Science-Sparte Merck
Millipore vorgestellt. 
Die komplette Pressemitteilung können Sie über folgenden Link
Merck Pressemitteilungen erreichen Sie unter folgender Adresse:
Merck KGaA
External Communications
Hotline: +49 (0) 6151/72-5000 
This message and any attachment are confidential and may be privileged or
otherwise protected from disclosure. If you are not the intended recipient,
you must not copy this message or attachment or disclose the contents to
any other person. If you have received this transmission in error, please
notify the sender immediately and delete the message and any attachment
from your system. Merck KGaA, Darmstadt, Germany and any of its
subsidiaries do not accept liability for any omissions or errors in this
message which may arise as a result of E-Mail-transmission or for damages
resulting from any unauthorized changes of the content of this message and
any attachment thereto. Merck KGaA, Darmstadt, Germany and any of its
subsidiaries do not guarantee that this message is free of viruses and does
not accept liability for any damages caused by any virus transmitted
Click to access the German, French, Spanish and
Portuguese versions of this disclaimer.
Press spacebar to pause and continue. Press esc to stop.